Related Experiment Video
Updated: Dec 27, 2025

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges
Published on: February 25, 2016
Factors Associated with Positive Adenosine Challenge Test in Young Children with Suspected Asthma
Gabriel Levin1, Shlomo Cohen2, Chaim Springer3
1Department of Obstetrics and Gynecology, Hadassah University Medical Center, Jerusalem, Israel.
Insights
Predictive factors for a positive adenosine monophosphate challenge with auscultation (AMP-PCW) test in children with suspected asthma include elevated eosinophils, immunoglobulin E (IgE) levels, and prior emergency department visits. These markers indicate airway inflammation and clinical exacerbation.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Diagnostic Testing
Background:
- Asthma diagnosis in young children can be challenging.
- The adenosine monophosphate challenge with auscultation (AMP-PCW) test is used to assess bronchial responsiveness.
- Identifying predictive factors for a positive AMP-PCW test can aid in diagnosis and management.
Purpose of the Study:
- To investigate factors predicting a positive adenosine monophosphate challenge with auscultation (AMP-PCW) test in children with suspected asthma.
- To identify independent determinants of positive AMP-PCW test results using multivariate logistic regression.
Main Methods:
- Prospective study involving young children with suspected asthma undergoing AMP-PCW testing.
- Comparison of patients with positive versus negative AMP-PCW test results.
- Multivariate logistic regression analysis to determine independent predictors.
Main Results:
- 54% of 159 children had a positive AMP-PCW test.
- Positive AMP-PCW was associated with higher prevalence of atopic dermatitis, family history of asthma/allergy, elevated IgE, peripheral blood eosinophils, and prior ED visits/hospitalizations.
- Peripheral blood eosinophils, IgE levels, and prior ED visits/hospitalizations were independent predictors of a positive AMP-PCW test.
Conclusions:
- Bronchial responsiveness to AMP-PCW in children is linked to airway inflammation markers (eosinophils, IgE) and clinical exacerbations.
- The AMP-PCW test may help detect inflammatory changes and monitor trends in young children with suspected asthma.
Abstract:
To investigate the predictive factors associated with positive adenosine monophosphate challenge using the auscultation method (AMP-PCW) test results. This is a prospective study of young children with suspected asthma who underwent AMP-PCW test. Patients with a positive AMP-PCW test were compared with those with a negative AMP-PCW. A multivariate logistic regression model was performed to identify the independent determinants of positive AMP-PCW. A total of 159 patients completed the AMP-PCW test. The median age was 53 months. In total, 54.0% of patients had a positive AMP-PCW. The prevalence of atopic dermatitis and family history of asthma and allergy were significantly higher among the positive AMP-PCW group (P = 0.04, P = 0.02, and P = 0.007, respectively), as were the prevalences of elevated immunoglobulin E (IgE), peripheral blood eosinophils percentage (P = 0.003, P < 0.001, respectively), and number of emergency department (ED) visits/hospitalizations before AMP-PCW test (P = 0.006). A significant inverse correlation exists between peripheral blood eosinophils percentage and serum IgE levels with the AMP end-point concentrations (r = -0.302, P = 0.001, and r = -0.312, P = 0.001, respectively). In multivariate logistic regression model, peripheral blood eosinophils percentage, IgE levels, and the number of ED visits/hospitalizations before the AMP-PCW test were found as independent predictors for positive AMP-PCW test result. Our results suggest that bronchial responsiveness to AMP-PCW is related to proxy markers of airway inflammation (elevated eosinophils and IgE levels) and clinical exacerbation of asthma before the test. This may support the role of AMP-PCW in detecting inflammatory changes and monitoring their trend among young children with suspected asthma.
Related Concept Videos
Asthma-I: Introduction
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications
Classification of Asthma
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...

